ABOS — Acumen Pharmaceuticals Inc
ABOS — Acumen Pharmaceuticals Inc — is admitted to trading on NASDAQ.
Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
Searching for the Acumen Pharmaceuticals Inc share price, or whether to buy ABOS? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.
VAQO runs a statistical model over ABOS that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.
What ABOS is
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies for the treatment of Alzheimer's disease and other neurodegenerative diseases. The company is headquartered in Charlottesville, Virginia.…
Acumen Pharmaceuticals Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ABOS size and valuation
At roughly $146.8M, ABOS is a micro-cap.
Earnings per share are negative at -1.64, so there is no meaningful price-to-earnings multiple to quote.
Beta is 0.33: historically it has moved less than the market.
ABOS over the past year
Over the past year ABOS has traded between $1.50 and $3.60, and the current price sits at -61% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $2.61 against a 200-day average of $2.51 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $7.60, 3,300.4% above it. A target is an aggregate of opinions, not a measurement.
How Acumen Pharmaceuticals Inc (ABOS) is trading
Acumen Pharmaceuticals Inc (ABOS) is up 4.54% at $0.22 — a more volatile session than average.
The session ranged from $0.21 to $0.23 — 6.8% of the share price — and the current price sits at 75% of that range.
It opened at 0% of the daily range and finished at 75% of it: ABOS turned around inside the session, in the buyers' favour.
Volume ran near 2.0M shares, about $448.3K of stock changing hands.
Traded alongside ABOS
Names traded alongside ABOS in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ABOS
Two statistical models run over ABOS inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Key facts
- Symbol: ABOS
- Name: Acumen Pharmaceuticals Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ABOS — frequently asked questions
What is the market cap of ABOS?
Acumen Pharmaceuticals Inc has a market capitalisation of roughly $146.8M.
What is the 52-week range for ABOS?
ABOS has traded between $1.50 and $3.60 over the past year, with the current price at -61% of that range.
How much does ABOS stock cost today?
Acumen Pharmaceuticals Inc (ABOS) trades at $0.22, a change of +4.54% in the latest session.
Is ABOS up or down today?
ABOS is up 4.54% in the latest session, at $0.22.
What is the daily trading range for ABOS?
ABOS traded between $0.21 and $0.23 in the latest session, and currently trades at $0.22.
What is the trading volume for ABOS?
ABOS traded roughly 2.0M shares in the latest session.
Which exchange is ABOS listed on?
ABOS is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ABOS stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ABOS figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Others in HEALTHCARE
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABSI — Absci Corp
Last updated: 2026-11-08